Back
Novo Nordisk A/S Vs. Ascendis Pharma A/S Industry Stock Comparison
Buy
76
NONOF
Novo Nordisk A/S
Last Price:
186.17
Seasonality Move:
-0.05%
Sell
46
ASND
Ascendis Pharma A/S
Last Price:
98.37
Seasonality Move:
7.2%
Buy
76
Novo Nordisk A/S (NONOF)
is a Buy
Is Novo Nordisk A/S a Buy, Sell or Hold?
- The current Novo Nordisk A/S [NONOF] share price is $186.17. The Score for NONOF is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- NONOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
46
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
- The current Ascendis Pharma A/S [ASND] share price is $98.27. The Score for ASND is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NONOF Stock Price Chart
What is Novo Nordisk A/S's stock price today?
-
The Novo Nordisk A/S share price today is $186.17
The current trend is moderately bullish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $98.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.
NONOF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 5.45 | Buy |
| Relative Strength Index (14 RSI): | 58.95 | Buy |
| Chaikin Money Flow: | -13054 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (167.61 - 191.33) | Buy |
| Bollinger Bands (100): | (156.17 - 176.99) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 59.2 | Buy |
| Chaikin Money Flow: | -22364 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (90.69 - 97.07) | Buy |
| Bollinger Bands (100): | (84.53 - 94.95) | Buy |
NONOF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 187.51 | Sell |
| 20-day SMA: | 184.79 | Buy |
| 50-day SMA: | 169.09 | Buy |
| 200-day SMA: | 151.58 | Buy |
| 8-day EMA: | 186.61 | Sell |
| 20-day EMA: | 182.4 | Buy |
| 50-day EMA: | 173.64 | Buy |
| 200-day EMA: | 152.96 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97.51 | Buy |
| 20-day SMA: | 94.13 | Buy |
| 50-day SMA: | 90.94 | Buy |
| 200-day SMA: | 101.55 | Sell |
| 8-day EMA: | 97.08 | Buy |
| 20-day EMA: | 94.85 | Buy |
| 50-day EMA: | 92.67 | Buy |
| 200-day EMA: | 97.56 | Buy |
Novo Nordisk A/S Earnings Growth & NONOF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $1.15 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.37 per share, an increase next quarter of $1.41 per share, a decrease this year of $0.53 per share, and an increase next year of $2.19 per share.
Novo Nordisk A/S Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma A/S Technical Analysis
| Aug 21 | Aug 22 | Aug 23 | Aug 24 | Aug 25 | Aug 28 | Aug 29 | Aug 30 | Aug 31 | Sep 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||